SCTV 01E1
Alternative Names: SCTV-01E-1Latest Information Update: 07 Sep 2022
At a glance
- Originator Sinocelltech
- Class COVID-19 vaccines; Protein vaccines; Subunit vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 02 Sep 2022 Preclinical trials in COVID-2019 infections in China (IM)
- 02 Sep 2022 Sinocelltech plans a phase-II trial for COVID-19 infections (Prevention)(NCT05522829)